206 related articles for article (PubMed ID: 30048602)
1. Evaluating the Completeness of ClinicalTrials.gov.
Stergiopoulos S; Getz KA; Blazynski C
Ther Innov Regul Sci; 2019 May; 53(3):307-317. PubMed ID: 30048602
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
Gresham G; Meinert JL; Gresham AG; Meinert CL
JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
[TBL] [Abstract][Full Text] [Related]
3. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial registry use in anaesthesiology systematic reviews: A cross-sectional study of systematic reviews published in anaesthesiology journals and the Cochrane Library.
Umberham BA; Detweiler BN; Sims MT; Vassar M
Eur J Anaesthesiol; 2017 Dec; 34(12):797-807. PubMed ID: 28731924
[TBL] [Abstract][Full Text] [Related]
5. Current landscape of type 1 diabetes mellitus-related interventional clinical trials registered on ClinicalTrials.gov: a cross-sectional study.
Liang R; Long J; Zheng Q; Yuan G; Chen X; Xin Z; Lai F; Liu Y
Acta Diabetol; 2021 Jun; 58(6):723-733. PubMed ID: 33543370
[TBL] [Abstract][Full Text] [Related]
6. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
7. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis.
Jones CW; Safferman MR; Adams AC; Platts-Mills TF
BMJ Open; 2017 Oct; 7(10):e017719. PubMed ID: 29025842
[TBL] [Abstract][Full Text] [Related]
10. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
Prayle AP; Hurley MN; Smyth AR
BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
Zwierzyna M; Davies M; Hingorani AD; Hunter J
BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
[TBL] [Abstract][Full Text] [Related]
12. Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.
Parker JL; Kuzulugil SS; Pereverzev K; Mac S; Lopes G; Shah Z; Weerasinghe A; Rubinger D; Falconi A; Bener A; Caglayan B; Tangri R; Mitsakakis N
Cancer Med; 2021 Mar; 10(6):1955-1963. PubMed ID: 33620160
[TBL] [Abstract][Full Text] [Related]
13. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
14. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
15. Gastroenterology Clinical Trials Transparency: An Analysis of Publication Rates From the ClinicalTrials.gov Database.
Garg S; Rizvi A; Wee D; Sreenivasan A; Suchman K; Thomas SL; Inamdar S; Trindade AJ
Am J Gastroenterol; 2022 Jan; 117(1):180-183. PubMed ID: 34534127
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields.
Schindler TM; Grieger F; Zak A; Rorig R; Chowdary Konka K; Ellsworth A; Pfitzer C; Hodge K; Crandall C;
PLoS One; 2020; 15(5):e0233294. PubMed ID: 32469901
[TBL] [Abstract][Full Text] [Related]
17. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
19. A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry.
McCoach CE; Berge EM; Lu X; Barón AE; Camidge DR
J Thorac Oncol; 2016 Mar; 11(3):407-13. PubMed ID: 26725180
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
